A new phase of trials to test two promising HIV vaccines began last week in London and Oxford. The vaccines—one made of naked DNA, the other a weakened pox virus—contain genes from a common strain of HIV in Africa, and should provoke an immune response that fends off the virus itself. Volunteers are receiving different combinations of the vaccines or a placebo. Teams at Imperial College in London and the Medical Research Council’s Human Immunology Unit in Oxford hope to recruit 120 volunteers aged 18 to 60, who must be HIV-negative.
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features
Mind
The relationship recession is even bigger for Gen Z than we thought
News
Technology
Killer robots are here – we must finally decide whether to accept them
Leader
Technology
Quantum computer quickly mines cryptocurrency while using less energy
News
Mind
How to sparkle in conversation with strangers
Comment
Popular articles
Trending New Scientist articles
1
The relationship recession is even bigger for Gen Z than we thought
2
How to sparkle in conversation with strangers
3
What is a ‘normal’ memory slowdown, and when should I worry?
4
Fully autonomous drones have killed human soldiers for the first time
5
Alice Roberts: The forgotten origins of the human body
6
First working nuclear clock heralds a new era in timekeeping
7
Understanding anorexia’s grip on the brain could unlock new therapies
8
What really happened when ancient humans migrated out of Africa
9
Hundreds of new moons are revealing our solar system's violent history
10
El Niño has started and the weather could get weird
